97
Bregma Capital Life Sciences Fund, LP files an open-ended hedge fund fund
New fund · Hedge fund · Pre-first close · SAN FRANCISCO, CA · Form D filed 2026-08-31
3(c)(7) — qualified purchasersPre-first closeFirst filing by this entityFirst-time managerNeeds prime broker / custodyPlacement agent engaged
Why now — by persona
Relevant to: Fund administrator, Fund audit & tax, Fund-formation counsel, Custodian / prime broker, Compliance consultant / RIA registration. Lead card pending.
People on the filing
| Mark E. Karvosky | CEO & CIO of Issuer's Investment Manager |
| - E. Bregma Capital GP, LLC | Issuer's General Partner |
| - E. Bregma Capital, LP | Issuer's Investment Manager |
Signed by Mark E. Karvosky, CEO & CIO of Issuer's Investment Manager.
Placement agents / sales compensation: Profor Securities, LLC
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.